Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir

Annals of Internal Medicine

Volumn 124, Issue 1 I, 1996, Pages 8-15

  Wald, Anna ^b   Zeh, Judith ^a   Barnum, Gail ^b   Davis, L G ^c   Corey, Lawrence ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Virology Research Clinic   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FEMALE; GENITAL HERPES; HUMAN; PRIORITY JOURNAL; VIRUS SHEDDING; VIRUS TRANSMISSION;

EID: 0030025629     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_1-199601010-00002     Document Type: Article

References (35)

1. Bryson YJ, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis. 1993, 167 942-6.
2. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor N Engl J Med 1991;324 1247-52
3. Mertz QJ, Coombs RW, Ashley R, Jourden J, Remington M, Winter C, et al. Transmission of genital herpes in couples with one symptomatic and one asymptomatic partner a prospective study. J Infect Dis 1988,157:1169-77
4. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992;116:197-202
5. Douglas JM, Critchlow C, Benedetti J, Mertz GJ, Connor JD, Hintz MA, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection N Engl J Med. 1984,310:1551-6.
6. Goldberg LH, Kaufman R, Kurtz TO, Conant MA, Eron LJ, Batenhorst RL, et al. Long-term suppression of recurrent genital herpes with acyclovir Arch Dermatol. 1993,129.582-7
7. Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection The Acyclovir Study Group JAMA 1991,256:747-51.
8. Straus SE, Takiff HE, Seidlin M, Bachrach S, Lininger L, DiGiovanna JJ. Suppression of frequently recurring genital herpes N Engl J Med. 1984,310: 1545-50
9. Mindel A, Faherty A, Camey O, Patou G, Freris M. Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet 1988;1 926-8.
10. Sacks SL, Fox R, Levendusky P, Stiver HG, Roland S, Nusinoff-Lehrman S, et al. Chronic suppression for six months compared with intermittent lesional therapy of frequently recurrent genital herpes using oral acyclovir. effects on lesions and nonlesional prodrome Sex Transm Dis 1988;15:58-62.
11. Straus SE, Seidlin M. Takiff HE, et al. Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes Sex Transm Dis 1989;16:107-12
12. Bowman CA, Woolley PD, Herman S, Clarke J, Kingdom GR. Asymptomatic herpes simplex virus shedding from the genital tract whilst on suppressive doses of oral acyclovir Int J STD and AIDS 1990;1:174-7.
13. Haddad J, Langer B, Astruc D, Messer J, Lokiec F. Oral acyclovir and recurrent genital herpes during late pregnancy. Obstet Gynecol. 1993;82: 102-4
14. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes Ann Intern Med 1992,116:433-7
15. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infection N Engl J Med 1995; 333:770-5
16. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L. Comparison of Western blot (Immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988;26:662-7
17. Brock BV, Selke S, Benedetti J, Douglas JM, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes JAMA. 1990;263:418-20.
18. Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue culture and diploid fibroblast microtiter plate system for the isolation of herpes simplex virus J Clin Microbiol 1988,26 1772-4
19. Lafferty WE, Krofft S, Remington M, Giddings R, Winter C, Cent A, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high prevalence population. J Clin Microbiol. 1987;25:323-6.
20. Sibrack CD, Gutman LT, Wilfert CM, McLaren C, St. Clair MH, Keller PM, et al Pathogenicity of acyclovir-resistant herpes simplex type 1 from an immunodeficient child J Infect Dis. 1982,146:73-82.
21. McLaren C, Ellis MN, Hunter GA. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 1983;3:223-34
22. Collins P, Ellis MN. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir J Med Virol 1993(Suppl 1),58-66.
23. Woods JR, Williams JG, Tavel M. The two-period crossover design in medical research. Ann Intern Med 1989;110:560-6.
24. Straus SE, Corey L, Burke RL. Savarese B, Barnum G, Krause PR, et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex type 2 for immunotherapy of genital herpes Lancet. 1994, 343:1460-3.
25. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first episode infection. Ann Intern Med 1994,121:847-54.
26. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 Ann intern Med. 1989,110:882-7
27. Reichman RC, Badger GJ, Mertz GJ, Corey L, Richman DD, Connor JD, et al. Treatment of recurrent genital herpes simplex infections with oral acydovir JAMA 1984, 251:2103-7
28. Nilsen AE, Aasen T, Halsos AM, Kinge BR, Tjotta EAL, Wikstrom K, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes Lancet 1982;2:571-3.
29. Fife K, Crumpacker CS, Mertz GJ, Hill EL, Boone GS. Recurrence and resistance patterns of herpes simplex virus following cessation of ≥6 years of chronic suppression with acyclovir. Acyclovir Study Group J Infect Dis. 1994; 169
30. Barton SE, Davis JM, Moss VW, Tyms AS, Munday PE. Asymptomatic shedding and subsequent transmission of genital herpes simplex virus Genitourin Med 1987,63:102-5.
31. Moore DE, Zarutskie PW, Soules MR, Coombs RW, Soules MR, Corey L. Transmission of genital herpes by donor insemination JAMA 1989,261: 3441-3
32. Rooney JJ, Felser JM, Ostrove JM, Straus SE. Acquisition of genital herpes from an asymptomatic sexual partner. N Engl J Med. 1986;314: 1561-4.
33. Swanson JM, Chenitz WC. Psychosocial aspects of genital herpes: a review of the literature. Public Health Nurs. 1990,7:96-104.
34. Cone RW, Hobson AC, Brown Z, Ashley R, Berry S, Winter C, et al. Frequent reactivation of genital herpes simplex viruses among pregnant women JAMA 1994;272 792-6
35. Centers for Disease Control and Prevention. 1993 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 1993;42:1-102